Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Takeda
Biotech
Takeda’s zasocitinib ‘top-notch’ for hard-to-treat psoriasis
Takeda demonstrated the once-daily pill was able to clear or almost clear psoriasis of the scalp in 75% of patients.
Marissa Russo
Jul 16, 2026 6:00pm
Insilico inks partnership via $600M biobuck collab with Takeda
Jul 1, 2026 8:30pm
A 5-month sprint: Inside Pfizer's $10B deal with Innovent
Jun 21, 2026 10:41pm
Intellia touts ‘paradigm-shifting’ HAE data
Jun 15, 2026 10:37am
Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown
Jun 11, 2026 7:00am
Innovent, fresh from $1.2B deal, posts key win for CLDN18.2 ADC
Jun 4, 2026 7:47am